PamelaNewMD

Clinical Trials

• COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors Start of enrollment: 2000 Jul 01

  Completed

  Phase 1, Phase 2

• Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma Start of enrollment: 2000 Jul 01

  Completed

  Phase 1, Phase 2

• Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01

  Active, not recruiting

  Phase 3

• Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma Start of enrollment: 2005 Mar 01

  Withdrawn

  Not Applicable

• Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01

  Completed

  Phase 3

• A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma Start of enrollment: 2010 Jul 01

  Completed

  Phase 1

• Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2011 Nov 01

  Completed

  Phase 3

• Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors Start of enrollment: 2007 Mar 01

  Withdrawn

  Phase 2

• Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma Start of enrollment: 2014 May 01

  Terminated

  Phase 1

• Join now to see all